Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9PT2F | — |
they gave a dose of Infanrix to a 25 year old patient; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 25-year-old female patient who received DTPa (Infanrix) (batch number 9PT2F, expiry date 10-MAR-2026) for prophylaxis. Previously administered products included Tetanus Diphtheria and Pertussis vaccine (received vaccine on 29-OCT-2011 with batch number AC528067BA). On 24-JAN-2025, the patient received Infanrix. On 24-JAN-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: they gave a dose of Infanrix to a 25 year old patient). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JAN-2025 Information received via Web Chat. The physician explained they gave a dose of Infanrix to a 25 year old patient on 24th January 2025 which led to inappropriate age at vaccine administration. The reporter mentioned that patient received a shot of Tetanus, Diphtheria, and Pertussis vaccine back on 29th October 2011 (they did not know the brand name, the only information was lot AC528067BA, GlaxoSmithKline).